Nathaniel E. David - 24 Jun 2022 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Director
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Nathaniel E. David
Issuer symbol
UBX
Transactions as of
24 Jun 2022
Net transactions value
$0
Form type
4
Filing time
27 Jun 2022, 17:36:17 UTC
Previous filing
28 Jun 2021
Next filing
26 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UBX Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 24 Jun 2022 Common Stock 25,000 $0.5900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 24, 2022 or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date.